Skip to main content
Fig. 3 | Cancer Cell International

Fig. 3

From: RBP7 functions as a tumor suppressor in HR + breast cancer by inhibiting the AKT/SREBP1 pathway and reducing fatty acid

Fig. 3

RBP7 expression in HR + BC clinical samples and cell lines. a Western blotting of the RBP7 level in HR + BC clinical samples, T: tumor, N: para-tumor. b Western blotting of the RBP7 level within 5 h + BC cells. c After downregulation of RBP7 expression in the T47D cell lines, the RBP7 expression was detected by Western blot and qRT-PCR. d After upregulation of RBP7 expression in the MCF7 and ZR-75-1 cell lines, the RBP7 expression was detected by Western blot and qRT-PCR. Data were represented as means ± S.D. of at least three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001

Back to article page